Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents

被引:22
作者
Solvik, Una O. [1 ]
Petersen, Per H. [1 ]
Monsen, Grete [2 ]
Stavelin, Anne V. [1 ,2 ]
Sandberg, Sverre [1 ,3 ]
机构
[1] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Fac Med & Dent, N-5020 Bergen, Norway
[2] Haraldsplass Hosp, Norwegian Qual Improvement Primary Care Labs NOKL, Bergen, Norway
[3] Haukeland Hosp, N-5021 Bergen, Norway
关键词
ORAL ANTICOAGULANT TREATMENT; PROTHROMBIN TIME; LUPUS ANTICOAGULANTS; TESTING DEVICES; INR; CALIBRATION; AGREEMENT; SENSITIVITY; REAGENTS; THERAPY;
D O I
10.1373/clinchem.2010.146233
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Observed differences between results obtained from comparison of instruments used to measure international normalized ratio (INR) have been higher than expected from the imprecision of the instruments. In this study the variation of these differences was divided into subcomponents, and each of the subcomponents was estimated. METHODS: Blood samples were collected at 4 different patient visits from each of 36 outpatients who were receiving warfarin treatment and were included in the study. INR was determined on 1 laboratory instrument (STA Compact (R)) and 3 point-of-care instruments (Simple Simon (R) PT, CoaguChek (R) XS, and INRatio (TM)). All 4 INR instruments were compared in pairs. Linear regression was used to correct for systematic deviations. The remaining variation of the differences was subdivided into between-subject, within-subject, and analytical variation in an ANOVA nested design. RESULTS: The mean difference between instruments varied between 1.0% and 14.3%. Between-subject variation of the differences (expressed as CV) varied between 3.3% and 7.4%, whereas within-subject variation of the differences was approximately 5% for all 6 comparisons. The analytical imprecision of the differences varied between 3.8% and 8.6%. CONCLUSIONS: The differences in INR between instruments were subdivided into calibration differences, between-and within-subject variation, and analytical imprecision. The magnitude of each subcomponent was estimated. Within results for individual patients the difference in INR between 2 instruments varied over time. The reasons for the between-and within-subject variations of the differences can probably be ascribed to different patient-specific effects in the patient plasma. To minimize this variation in a monitoring situation, each site and patient should use results from only 1 type of instrument. (c) 2010 American Association for Clinical Chemistry
引用
收藏
页码:1618 / 1626
页数:9
相关论文
共 46 条
[31]   International Normalized Ratio of Prothrombin Time in the Model for End-stage Liver Disease Score: An Unreliable Measure [J].
Arjal, Russ ;
Trotter, James F. .
CLINICS IN LIVER DISEASE, 2009, 13 (01) :67-+
[32]   The association between warfarin usage and international normalized ratio increase: systematic analysis of FDA Adverse Event Reporting System (FAERS) [J].
Morris, Robert ;
Todd, Megan ;
Aponte, Nicole Zapata ;
Salcedo, Milagros ;
Bruckner, Matthew ;
Garcia, Alfredo Suarez ;
Webb, Rachel ;
Bu, Kun ;
Han, Weiru ;
Cheng, Feng .
JOURNAL OF CARDIOVASCULAR AGING, 2023, 3 (04)
[33]   Problem Solved? An Individual Ratio between Point-of-Care and Venous International Normalized Ratio Values in Two Patients with Antiphospholipid Syndrome: Two Case Reports [J].
Geertsema-Hoeve, Bettina C. ;
Radin, Massimo ;
Sciascia, Savino ;
Urbanus, Rolf T. ;
Huisman, Albert ;
Borgsteede-de Wilde, Josine ;
Limper, Maarten .
TH OPEN, 2025, 09
[34]   Mathematical model and calculation to predict the effect of prophylactic plasma transfusion on change in international normalized ratio in critically ill patients with coagulopathy [J].
Pham, Huy P. ;
Muller, Marcella C. ;
Williams, Lance A., III ;
Juffermans, Nicole P. .
TRANSFUSION, 2016, 56 (04) :926-932
[35]   Low-Dose Warfarin With Prothrombin Time-International Normalized Ratio Between 1.6 and 2.6 for Very Old Japanese Patients [J].
Yasaka, Masahiro .
CIRCULATION JOURNAL, 2015, 79 (11) :2314-2316
[36]   Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration [J].
Rosborough, Terry K. ;
Jacobsen, Jennifer M. ;
Shepherd, Michele F. .
BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (06) :433-435
[37]   The Association Between Preoperative International Normalized Ratio Values and Postoperative Outcomes including Mortality in Geriatric Femoral Neck Fractures Treated With Hemiarthroplasty [J].
Uvodich, Mason E. ;
Dugdale, Evan M. ;
Duong, Stephanie Q. ;
Cancio-Bello, Alexandra ;
Sems, Stephen A. ;
Yuan, Brandon J. J. .
JOURNAL OF ORTHOPAEDIC TRAUMA, 2023, 37 (05) :230-236
[38]   Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation - Results of the J-RHYTHM Registry - [J].
Inoue, Hiroshi ;
Okumura, Ken ;
Atarashi, Hirotsugu ;
Yamashita, Takeshi ;
Origasa, Hideki ;
Kumagai, Naoko ;
Sakurai, Masayuki ;
Kawamura, Yuichiro ;
Kubota, Isao ;
Matsumoto, Kazuo ;
Kaneko, Yoshiaki ;
Ogawa, Satoshi ;
Aizawa, Yoshifusa ;
Chinushi, Masaomi ;
Kodama, Itsuo ;
Watanabe, Eiichi ;
Koretsune, Yukihiro ;
Okuyama, Yuji ;
Shimizu, Akihiko ;
Igawa, Osamu ;
Bando, Shigenobu ;
Fukatani, Masahiko ;
Saikawa, Tetsunori ;
Chishaki, Akiko .
CIRCULATION JOURNAL, 2013, 77 (09) :2264-2270
[39]   Reexamining the Recommended Follow-up Interval After Obtaining an In-Range International Normalized Ratio Value Results from the Veterans Affairs Study to Improve Anticoagulation [J].
Rose, Adam ;
Ozonoff, Al ;
Berlowitz, Dan R. ;
Ash, Arlene S. ;
Reisman, Joel I. ;
Hylek, Elaine M. .
CHEST, 2011, 140 (02) :359-365
[40]   Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility ofBacteroides fragilisto Antibiotics [J].
Yagi, Tatsuya ;
Naito, Takafumi ;
Kato, Ayami ;
Hirao, Kensho ;
Kawakami, Junichi .
ANNALS OF PHARMACOTHERAPY, 2021, 55 (02) :157-164